Search research articles
Contact Us
Filters
Showing results (11-20 of 116) with videos related to
Page
of 12
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism
|
February 23, 2007
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients
Martin Schlumberger, Ludovic Lacroix, Diego Russo, et al.
Pharmacological Research
|
February 18, 2019
Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies
Marilena Celano, Valentina Maggisano, Saverio Massimo Lepore, et al.
Endocrine
|
February 15, 2021
Phytochemicals in thyroid cancer: analysis of the preclinical studies
Stefania Bulotta, Francesca Capriglione, Marilena Celano, et al.
Molecular and Cellular Endocrinology
|
September 18, 2012
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines
Elisa Lavarone, Cinzia Puppin, Nadia Passon, et al.
Journal of Translational Medicine
|
August 4, 2014
Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases
Stefania Bulotta, Marilena Celano, Saverio Massimo Lepore, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 7, 2009
Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate
Rocco Bruno, Paolo Giannasio, Rosarita Chiarella, et al.
International Journal of Endocrinology
|
February 24, 2015
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
Federica Baldan, Catia Mio, Lorenzo Allegri, et al.
Expert Opinion on Therapeutic Targets
|
December 14, 2012
Targeting histone deacetylase in thyroid cancer
Diego Russo, Cosimo Durante, Stefania Bulotta, et al.
Oncology Reports
|
February 18, 2016
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
Lorenzo Allegri, Federica Baldan, Catia Mio, et al.
International Journal of Genomics
|
October 18, 2017
MicroRNAs as Biomarkers in Thyroid Carcinoma
Marilena Celano, Francesca Rosignolo, Valentina Maggisano, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 116) with videos related to
Sort By:
Page
of 12
Nature Clinical Practice. Endocrinology & Metabolism
|
February 23, 2007
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients
Martin Schlumberger, Ludovic Lacroix, Diego Russo, et al.
Pharmacological Research
|
February 18, 2019
Secoiridoids of olive and derivatives as potential coadjuvant drugs in cancer: A critical analysis of experimental studies
Marilena Celano, Valentina Maggisano, Saverio Massimo Lepore, et al.
Endocrine
|
February 15, 2021
Phytochemicals in thyroid cancer: analysis of the preclinical studies
Stefania Bulotta, Francesca Capriglione, Marilena Celano, et al.
Molecular and Cellular Endocrinology
|
September 18, 2012
The PARP inhibitor PJ34 modifies proliferation, NIS expression and epigenetic marks in thyroid cancer cell lines
Elisa Lavarone, Cinzia Puppin, Nadia Passon, et al.
Journal of Translational Medicine
|
August 4, 2014
Beneficial effects of the olive oil phenolic components oleuropein and hydroxytyrosol: focus on protection against cardiovascular and metabolic diseases
Stefania Bulotta, Marilena Celano, Saverio Massimo Lepore, et al.
Thyroid : Official Journal of the American Thyroid Association
|
May 7, 2009
Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate
Rocco Bruno, Paolo Giannasio, Rosarita Chiarella, et al.
International Journal of Endocrinology
|
February 24, 2015
Synergy between HDAC and PARP Inhibitors on Proliferation of a Human Anaplastic Thyroid Cancer-Derived Cell Line
Federica Baldan, Catia Mio, Lorenzo Allegri, et al.
Expert Opinion on Therapeutic Targets
|
December 14, 2012
Targeting histone deacetylase in thyroid cancer
Diego Russo, Cosimo Durante, Stefania Bulotta, et al.
Oncology Reports
|
February 18, 2016
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
Lorenzo Allegri, Federica Baldan, Catia Mio, et al.
International Journal of Genomics
|
October 18, 2017
MicroRNAs as Biomarkers in Thyroid Carcinoma
Marilena Celano, Francesca Rosignolo, Valentina Maggisano, et al.
Page
of 12